Mentoring scheme involving Exeter highlighted in new Wellcome report
The GW4 Antimicrobial Resistance (AMR) Alliance’s innovative cross-institutional mentorship scheme across the GW4 universities of Bath, Bristol, Cardiff and Exeter,...
MRC Centre for Medical Mycology
Global mycology community calls to combat drug‑resistant fungi
Fifty researchers from across the world have joined forces to create a new five-step plan to protect vulnerable patients from...
Exeter led international collaboration given £4.5 million to tackle deadly fungal disease
An international collaboration led by the University of Exeter has been awarded £4.5 million to help improve understanding of fungal diseases that kill 2.5 million people each year. The funding from Wellcome...
TB harnesses part of immune defence system to cause infection
Scientists have made a discovery that helps explain why humans and animals are so susceptible to contracting tuberculosis(TB) – and...
Revealed: genetic process which could be treatment target for deadly fungal disease Candida auris
Scientists have discovered a genetic process which could unlock new ways to treat mysterious and deadly fungal infection which has...
Tackling deadly fungal threats: Global training empowers clinicians and lab technicians
Twenty-four clinicians and laboratory technicians have enrolled in a bespoke training programme designed to strengthen the diagnosis and treatment of deadly fungal...
University researchers ranked among the most influential in the world
Scientists at the University of Exeter have been ranked among the most influential and respected in the world according to...
Vice-Chancellor strengthens health and conservation research links in visit to South Africa
A delegation from the University of Exeter has met with the British High Commissioner to South Africa during a visit...
Exeter boosts global fight against antifungal resistance with £2.8m funding
As the threat of drug‑resistant fungal infections grows into a serious global health concern, the University of Exeter is taking...